Formation of Solid Solutions Between Racemic and Enantiomeric Citalopram Oxalate

被引:23
作者
de Diego, Heidi Lopez [1 ]
Bond, Andrew D. [3 ]
Dancer, Robert James [2 ]
机构
[1] H Lundbeck & Co AS, Dept Preformulat, Copenhagen, Denmark
[2] H Lundbeck & Co AS, Dept Proc Res, Copenhagen, Denmark
[3] Univ So Denmark, Dept Chem & Phys, Odense, Denmark
关键词
escitalopram oxalate; citalopram; racemic compound; crystal structure; isostructural; solid solutions; ternary phase diagram; binary phase diagram; disorder; ESCITALOPRAM; RESOLUTION; SYSTEM; ACID;
D O I
10.1002/chir.20943
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The X-ray powder diffractograms of racemic citalopram oxalate and (S)-citalopram oxalate are very similar, but the melting point of the racemate is higher than that of the pure enantiomer. The higher melting point indicates that the racemate is a racemic compound, rather than a conglomerate. The crystal structure of the enantiomer contains two molecules of (S)-citalopram in the asymmetric unit. The conformation of the two molecules is different but they approximate mirror images of each other if the aromatic groups are interchanged. The crystal structure of the racemate is essentially isostructural with that of the enantiomer, having almost the same cell parameters but containing a crystallographic inversion centre that is not retained in the enantiomer structure. The closely-comparable crystal structures permit solid solutions to be formed between racemic and enantiomeric citalopram oxalate. Phase diagrams of the (R)-citalopram and (S)-citalopram oxalate system are constructed, and they show that solid solutions are formed at all ratios of the two enantiomers. Chirality 23: 408-416, 2011. (c) 2011 Wiley-Liss, Inc.
引用
收藏
页码:408 / 416
页数:9
相关论文
共 16 条
[1]  
*BRUK AXS, 2004, APEX 2 VERS 1 0 22
[2]   Escitalopram [J].
Burke, WJ .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (10) :1477-1486
[3]   Purification of partially resolved enantiomeric mixtures with the guidance of ternary phase diagram [J].
Chen, Alex M. ;
Wang, Yaling ;
Wenslow, Robert M. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (02) :271-281
[4]   Attempted Resolution of Citalopram Using (-)-O,O′-Di-p-toluoyl-(R,R)-tartaric Acid, and Reflections on an Alkylation Reaction; Comment on an Article by Elati et al. [J].
Dancer, Robert James ;
de Diego, Heidi Lopez .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (01) :23-33
[5]   Substrate modification approach to achieve efficient resolution: Didesmethylcitalopram: A key intermediate for escitalopram [J].
Elati, Chandrashekar R. ;
Kolla, Naveenkumar ;
Vankawala, Pravinchandra J. ;
Gangula, Srinivas ;
Chalamala, Subrahmanyeswarara ;
Sundaram, Venkatraman ;
Bhattacharya, Apurba ;
Vurimidi, Himabindu ;
Mathad, Vijayavitthal T. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (02) :289-292
[6]   Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal [J].
Harrison, William T. A. ;
Yathirajan, H. S. ;
Bindya, S. ;
Anilkumar, H. G. ;
Devaraju .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2007, 63 :O129-O131
[7]   Discovery of a solid solution of enantiomers in a racemate-forming system by seeding [J].
Huang, Jun ;
Chen, Shuang ;
Guzei, Ilia A. ;
Yu, Lian .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (36) :11985-11992
[8]   THE PHARMACOLOGICAL EFFECT OF CITALOPRAM RESIDES IN THE (S)-(+)-ENANTIOMER [J].
HYTTEL, J ;
BOGESO, KP ;
PERREGAARD, J ;
SANCHEZ, C .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 88 (02) :157-160
[9]  
Jacques J., 1981, Enantiomers, Racemates and Resolutions
[10]  
Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI [10.1107/S002188980600731X, 10.1107/S0021 88980600731X]